LKFT — Lakefront Biotherapeutics NV Share News
0.000.00%
Last trade - 00:00- €1.77bn
- -€467.06m
- €1.11bn
Barclays cautious on European pharma in H1, sees re-rating chance in H2
U.S. STOCKS ON THE MOVE-Galapagos, Tapestry, Autodesk
Galapagos to spin off innovative medicines business (updated)
Dutch pharma group Galapagos jumps 11% on planned split
Netherland's Galapagos to spin off innovative medicines unit (updated)
Corrected: Netherland's Galapagos to spin off innovative medicines unit
Brief: Galapagos Intends To Separate Into Two Publicly Traded Entities
Kepler cuts Galapagos on 'Pyrrhic gamble' strategy
Galapagos NV reports results for the quarter ended in September 30 - Earnings Summary
Brief: Galapagos Says 9m Net Profit Of Period EUR 48.8 Million
French and Benelux stocks-Factors to watch
Europe Research Roundup: Basler AG, Greatland Gold, Sandvik AB
U.S. RESEARCH ROUNDUP-Galapagos, Marsh & Mclennan, Travelers
Galapagos jumps after appointing EcoR1's Nodelman to its board
Brief: Galapagos Receives Transparency Notification From Ecor1 Capital
Brief: Ecor1 Capital Reports 9.9% Stake In Galapagos NV As Of Aug 19
Galapagos rises on FDA clearance for phase 1/2 ATALANTA-1 study
Brief: Galapagos: FDA Clears IND Application For Phase 1/2 ATALANTA-1 Study
Europe Research Roundup: Ashtead Group, Beazley, Entain